Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$0.28 - $1.16 $8,595 - $35,609
-30,698 Reduced 17.18%
148,036 $48,000
Q1 2024

Apr 25, 2024

BUY
$1.06 - $1.67 $32,539 - $51,265
30,698 Added 20.74%
178,734 $207,000
Q4 2023

Jan 30, 2024

SELL
$1.26 - $1.79 $46,273 - $65,737
-36,725 Reduced 19.88%
148,036 $250,000
Q3 2023

Oct 25, 2023

BUY
$1.61 - $2.54 $80,221 - $126,560
49,827 Added 36.93%
184,761 $334,000
Q4 2022

Feb 01, 2023

BUY
$1.63 - $3.52 $106,913 - $230,880
65,591 Added 94.59%
134,934 $228,000
Q2 2022

Aug 09, 2022

BUY
$2.2 - $4.2 $152,554 - $291,240
69,343 New
69,343 $165,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $13.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.